Bloomberg.com
Aug. 15 (Bloomberg) -- Staar Surgical Co. insiders and investors are buying stock as they bet the company's $3,081 lens implants to correct nearsightedness will gain on less-costly Lasik treatments, increasing the potential for a takeover.